Zenas Biopharma (usa), Llc

This study tests an experimental drug called obexelimab in 93 adults with relapsing multiple sclerosis. The goal is to see if it reduces new brain lesions and is safe. Participants receive either the drug or a placebo, and neither they nor their doctors know which one they get.

This study tests an experimental drug called obexelimab to see if it can prevent flare-ups in people with IgG4-related disease, a rare condition that causes swelling and damage in organs. About 194 adults with active disease will receive either the drug or a placebo. The main goa…